Kilian Guse, PhD

The vice president of genetic medicine platforms at Pacira.

Articles by Kilian Guse, PhD

High-Capacity Adenovirus Vectors for Gene Therapy

ByDerek Jackson, BS, MA,Kilian Guse, PhD,Noah Stansfield

July 14th 2025

Derek Jackson, BS, MA, and Kilian Guse, PhD, of Pacira Biosciences, discussed the company’s symposium at ASGCT 2025.

Derek Jackson, BS, MA, the vice president of cell & gene therapy product development at Pacira, and Kilian Guse, PhD, the vice president of genetic medicine platforms at Pacira

Derek Jackson, BS, MA, and Kilian Guse, PhD, on High-Capacity Adenovirus Vectors for Gene Therapy

ByDerek Jackson, BS, MA,Kilian Guse, PhD,Noah Stansfield

July 9th 2025

The vice president of cell & gene therapy product development and the vice president of genetic medicine platforms at Pacira discussed the company’s symposium at ASGCT 2025.

Kilian Guse, PhD

Articles by Kilian Guse, PhD

High-Capacity Adenovirus Vectors for Gene Therapy

Derek Jackson, BS, MA, and Kilian Guse, PhD, on High-Capacity Adenovirus Vectors for Gene Therapy

Latest Updated Articles

Trending on CGTlive®

Around the Helix: Cell and Gene Therapy Company Updates – October 8, 2025

Neurogene Reaches Accord With FDA on Plan for Registrational Trial for Rett Syndrome Gene Therapy NGN-401

Avobis Bio's Crohn Disease Cell Therapy AVB-114 Garners FDA RMAT Designation